Maravai LifeSciences Holdings, Inc. (MRVI)
Largest Insider Buys in Sector
MRVI Stock Price History Chart
MRVI Stock Performance
About Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of …
Insider Activity of Maravai LifeSciences Holdings, Inc.
Over the last 12 months, insiders at Maravai LifeSciences Holdings, Inc. have bought $0 and sold $97.57M worth of Maravai LifeSciences Holdings, Inc. stock.
On average, over the past 5 years, insiders at Maravai LifeSciences Holdings, Inc. have bought $4.71M and sold $97.57M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 35,000 shares for transaction amount of $942,900 was made by HULL CARL (Chief Executive Officer) on 2020‑11‑25.
List of Insider Buy and Sell Transactions, Maravai LifeSciences Holdings, Inc.
| 2024-05-28 | Sale | 9.94M 6.814% | $9.81 | $97.57M | -21.10% | |||
| 2020-11-25 | Chief Executive Officer | 35,000 0.0865% | $26.94 | $942,900 | +39.24% | |||
| 2020-11-24 | director | 50,000 0.127% | $27.00 | $1.35M | +42.73% | |||
| 2020-11-24 | director | 20,000 0.0508% | $27.00 | $540,000 | +42.73% | |||
| 2020-11-24 | director | 18,000 0.0457% | $27.00 | $486,000 | +42.73% | |||
| 2020-11-24 | director | 15,000 0.0381% | $27.00 | $405,000 | +42.73% | |||
| 2020-11-24 | director | 10,000 0.0254% | $27.00 | $270,000 | +42.73% | |||
| 2020-11-24 | See Remarks | 18,888 0.048% | $27.00 | $509,976 | +42.73% | |||
| 2020-11-24 | General Counsel | 7,500 0.019% | $27.00 | $202,500 | +42.73% |
Insider Historical Profitability
| Hopfield Jessica | director | 61852 0.0245% | $8.04 | 1 | 0 | +42.73% |
| HULL CARL | Chief Executive Officer | 35000 0.0139% | $8.04 | 1 | 0 | +39.24% |
| GRAY SUSANNAH | director | 31852 0.0126% | $8.04 | 1 | 0 | +42.73% |
| PRAHALAD MURALI | director | 29852 0.0118% | $8.04 | 1 | 0 | +42.73% |
| LUCIER GREGORY T | director | 26852 0.0106% | $8.04 | 1 | 0 | +42.73% |
Institutional Investor Ownership
| GTCR | $187.97M | 8.61 | 21.68M | 0% | +$0 | 15.96 | |
| 12 West Capital Management LP | $114.47M | 5.24 | 13.2M | +13.79% | +$13.87M | 10.44 | |
| The Vanguard Group | $87.03M | 3.99 | 10.04M | +0.34% | +$296,791.44 | <0.01 | |
| Braidwell Lp | $62.61M | 2.87 | 7.22M | +43.27% | +$18.91M | 3.55 | |
| BlackRock | $55.61M | 2.55 | 6.41M | -1.03% | -$581,271.48 | <0.01 |